Get Published | Subscribe | About | Write for Our Blog    

News RSS Bioethics News.


Years after an experimental stem cell therapy blinded patients, the FDA is still trying to stop it

External Link - Source: The Washington Post

The Food and Drug Administration promised yesterday to heighten oversight of providers of experimental stem cell treatments, as a Post report detailed the agency’s slow response to a leading stem cell company whose treatments blinded some patients.

This entry was posted in Health Regulation & Law, Public Health, Research Ethics and tagged . Bookmark the permalink.